(RARE) Ultragenyx Pharmaceutical complete technical analysis [charts+indicators] | Buy/Sell Ultragenyx Pharmaceutical | (RARE) share price targets
Complete technical analysis of Ultragenyx Pharmaceutical (RARE) by charts plus indicators, forecast predictions and share price targets for Ultragenyx Pharmaceutical (RARE)
Ultragenyx Pharmaceutical trades in USA in Health Care sector.
Showing technical analysis as on 2025-02-12 View latest technical analysis
10 day averaged volume of Ultragenyx Pharmaceutical is 570890
Date | Daily Closing Price | Open | High | Low | Volume |
12 Wed Feb 2025 | 43.43 | 42.87 | 43.74 | 42.52 | 1.112 times |
11 Tue Feb 2025 | 43.58 | 44.20 | 45.02 | 43.49 | 1.001 times |
10 Mon Feb 2025 | 44.78 | 45.56 | 45.67 | 44.65 | 1.015 times |
07 Fri Feb 2025 | 45.35 | 45.73 | 46.15 | 45.02 | 1.21 times |
06 Thu Feb 2025 | 45.78 | 45.38 | 46.50 | 44.68 | 1.334 times |
05 Wed Feb 2025 | 45.37 | 44.37 | 45.64 | 44.19 | 0.971 times |
04 Tue Feb 2025 | 44.18 | 43.23 | 44.53 | 43.23 | 0.872 times |
03 Mon Feb 2025 | 43.42 | 42.19 | 44.13 | 41.89 | 1.322 times |
31 Fri Jan 2025 | 43.03 | 43.62 | 43.83 | 42.75 | 0.817 times |
30 Thu Jan 2025 | 43.40 | 42.70 | 43.91 | 42.31 | 0.768 times |
My analysis of stock is bullish for shortterm, and stock might move up till 44.9 or till 46.8. Use a stoploss of 43.23 and if this stock hits its stoploss, then it can fall down till 41.59
Share price targets for Ultragenyx Pharmaceutical (RARE)
Target Type | Value |
Downside Target | 39.79 |
Downside Target | 41.26 |
Upside Target | 44.66 |
Upside Target | 45.67 |
Upside Target | 46.24 |
Upside Target | 46.50 |
Upside Target | 50.00 |
Upside Target | 50.76 |
Upside Target | 53.47 |
Upside Target | 58.00 |
Intraday share price targets for Ultragenyx Pharmaceutical (RARE)
Target Type | Value |
Downside Intraday Target | 42.08 |
Downside Intraday Target | 40.72 |
Upside Intraday Target | 45.23 |
Upside Intraday Target | 47.02 |
Upside Intraday Target | 43.87 |
Weekly technical analysis of Ultragenyx Pharmaceutical (RARE)
Date | Weekly Closing Price | Open | High | Low | Volume |
12 Wed Feb 2025 | 43.43 | 45.56 | 45.67 | 42.52 | 0.548 times |
07 Fri Feb 2025 | 45.35 | 42.19 | 46.50 | 41.89 | 1.259 times |
31 Fri Jan 2025 | 43.03 | 43.84 | 44.66 | 42.11 | 0.609 times |
24 Fri Jan 2025 | 44.05 | 40.47 | 45.48 | 40.01 | 5.344 times |
17 Fri Jan 2025 | 40.00 | 41.22 | 41.50 | 39.99 | 0.137 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Ultragenyx Pharmaceutical (RARE)
Date | Monthly Closing Price | Open | High | Low | Volume |
12 Wed Feb 2025 | 43.43 | 42.19 | 46.50 | 41.89 | 0.234 times |
31 Fri Jan 2025 | 43.03 | 42.26 | 46.24 | 39.79 | 1.726 times |
31 Tue Dec 2024 | 42.07 | 49.50 | 50.00 | 41.26 | 0.703 times |
26 Tue Nov 2024 | 47.36 | 51.14 | 53.47 | 43.04 | 1.233 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Ultragenyx Pharmaceutical (RARE)
Price action analysis of Ultragenyx Pharmaceutical ( (RARE) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Ultragenyx Pharmaceutical ( (RARE) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ultragenyx Pharmaceutical ( (RARE) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ultragenyx Pharmaceutical ( (RARE) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Ultragenyx Pharmaceutical stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Ultragenyx Pharmaceutical in short term but the buy signal is initial and weak.
Ultragenyx Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Ultragenyx Pharmaceutical in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Ultragenyx Pharmaceutical is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 44.31 and Ultragenyx Pharmaceutical (RARE) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Ultragenyx Pharmaceutical (RARE) stock. Volume based technical analysis of Ultragenyx Pharmaceutical (RARE) stock is negative.
Ultragenyx Pharmaceutical Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Ultragenyx Pharmaceutical ( (RARE) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Ultragenyx Pharmaceutical ( (RARE) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ultragenyx Pharmaceutical ( (RARE) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ultragenyx Pharmaceutical ( (RARE) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Ultragenyx Pharmaceutical stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Ultragenyx Pharmaceutical in short term but the buy signal is initial and weak.
Ultragenyx Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Ultragenyx Pharmaceutical in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Ultragenyx Pharmaceutical is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 44.31 and Ultragenyx Pharmaceutical (RARE) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Ultragenyx Pharmaceutical (RARE) stock. Volume based technical analysis of Ultragenyx Pharmaceutical (RARE) stock is negative.
Ultragenyx Pharmaceutical Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.